CPA Welcomes FDA Proposal to Expose Hidden Foreign Suppliers in America’s Drug Supply Chain

CPA Welcomes FDA Proposal to Expose Hidden Foreign Suppliers in America’s Drug Supply Chain

New visibility into upstream API and key starting material producers lays the groundwork for origin labeling, procurement preferences, and reshoring incentives WASHINGTON, D.C. — The Coalition for a Prosperous America (CPA) today welcomed a proposed rule issued by the Food and Drug Administration that would require foreign establishments manufacturing active pharmaceutical ingredients (APIs) and other …

FDA Quietly Moves to Reshape America’s Drug Supply Chain

For years, the debate over prescription drugs has centered on one question: Why does the United States depend so heavily on foreign manufacturers for medicines that millions of Americans rely on every day? Now the Food and Drug Administration is proposing a regulatory overhaul that could begin changing that equation. The agency announced a proposed...

FDA Plan Would Cut Drug Factory Registration Burdens

WASHINGTON, D.C. — The Food and Drug Administration proposed easing registration requirements for distributed drug manufacturing networks last week while expanding oversight of foreign facilities that supply ingredients entering the …